Timing of bacterial carriage sampling in vaccine trials: A modelling study

Epidemics

Volumn 9, Issue , 2014, Pages 8-17

  Scott, Pippa ^a   Herzog, Sereina A ^a,b   Auranen, Kari ^c   Dagan, Ron ^d   Low, Nicola ^a   Egger, Matthias ^a,e   Heijne, Janneke C M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Bacterial pathogens; Mathematical modelling; Methodological research; Randomised controlled trials; Vaccine efficacy

Indexed keywords

BACTERIAL VACCINE; VACCINE;

ARTICLE; BACTERIUM CARRIER; COMPARTMENT MODEL; CROSS-SECTIONAL STUDY; DRUG CLEARANCE; DRUG EFFICACY; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SAMPLING; SENSITIVITY ANALYSIS; SIMULATION; BIOLOGICAL MODEL; CONTROLLED STUDY; HETEROZYGOTE; IMMUNOLOGY; MICROBIOLOGY; NASOPHARYNX; PATHOLOGY; PNEUMOCOCCAL INFECTION; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE;

CARRIER STATE; CROSS-SECTIONAL STUDIES; HUMANS; MODELS, IMMUNOLOGICAL; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VACCINES;

EID: 84907994968     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.08.003     Document Type: Article

References (31)

1. Abdullahi O., Karani A., Tigoi C.C., Mugo D., Kungu S., Wanjiru E., Jomo J., Musyimi R., Lipsitch M., Scott J.A. Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in kilifi district, kenya. J. Infect. Dis. 2012, 206(7):1020-1029. 10.1093/infdis/jis447.
2. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among gambian children. J. Infect. Dis. 1998, 177(6):1758-1761.
3. Auranen K., Ranta J., Takala A.K., Arjas E. A statistical model of transmission of hib bacteria in a family. Stat. Med. 1996, 15(20):2235-2252. 10.1002/(SICI)1097-0258(19961030)15:20<2235::AID-SIM354>3.0.CO;2-G.
4. Auranen K., Arjas E., Leino T., Takala A.K. Transmission of pneumococcal carriage in families: a latent markov process model for binary longitudinal data. J. Am. Stat. Assoc. 2000, 95(452):1044-1053.
5. Auranen K., Mehtala J., Tanskanen A., Kaltoft M.S. Between-strain competition in acquisition and clearance of pneumococcal carriage - epidemiologic evidence from a longitudinal study of day-care children. Am. J. Epidemiol. 2010, 171(2):169-176. 10.1093/aje/kwp351.
6. Auranen K., Rinta-Kokko H., Goldblatt D., Nohynek H., O'Brien K.L., Satzke C., Simell B., Tanskanen A., Kayhty H. Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint. Vaccine 2013, 10.1016/j.vaccine.2013.06.105.
7. Auranen K., Rinta-Kokko H., Halloran M.E. Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study. Biometrics 2013, 69(1):235-244. 10.1111/j.1541-0420.2012.01826.x.
8. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 1995, 171(1):93-98.
9. Dagan R., Givon-Lavi N., Fraser D., Lipsitch M., Siber G.R., Kohberger R. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J. Infect. Dis. 2005, 192(3):367-376. 10.1086/431679.
10. Dagan R., Givon-Lavi N., Porat N., Greenberg D. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine 2012, 30(34):5132-5140. 10.1016/j.vaccine.2012.05.059.
11. Dagan R., Givon-Lavi N., Zamir O., Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr. Infect. Dis. J. 2003, 22(6):532-540. 10.1097/01.inf.0000069761.11093.c3.
12. Daugla D.M., Gami J.P., Gamougam K., Naibei N., Mbainadji L., Narbe M., Toralta J., Kodbesse B., Ngadoua C., Coldiron M.E., Fermon F., Page A.L., Djingarey M.H., Hugonnet S., Harrison O.B., Rebbetts L.S., Tekletsion Y., Watkins E.R., Hill D., Caugant D.A., Chandramohan D., Hassan-King M., Manigart O., Nascimento M., Woukeu A., Trotter C., Stuart J.M., Maiden M.C., Greenwood B.M. Effect of a serogroup a meningococcal conjugate vaccine (psa-tt) on serogroup a meningococcal meningitis and carriage in chad: a community study [corrected]. Lancet 2014, 383(9911):40-47. 10.1016/S0140-6736(13)61612-8.
13. Givon-Lavi N., Greenberg D., Dagan R. Immunogenicity of alternative regimens of the conjugated 7-valent pneumococcal vaccine a randomized controlled trial. Pediatr. Infect. Dis. J. 2010, 29:756-762.
14. Halloran M.E., Longini I.M., Struchiner C.J. Design and interpretation of vaccine field studies. Epidemiol. Rev. 1999, 21(1):73-88.
15. Halloran M.E., Struchiner C.J. Causal inference in infectious diseases. Epidemiology 1995, 6(2):142-151.
16. Halloran M.E., Struchiner C.J., Longini I.M. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am. J. Epidemiol. 1997, 146(10):789-803.
17. Melegaro A., Gay N.J., Medley G.F. Estimating the transmission parameters of pneumococcal carriage in households. Epidemiol. Infect. 2004, 132(3):433-441.
18. Mina M.J., Klugman K.P., McCullers J.A. Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice. J. Infect. Dis. 2013, 10.1093/infdis/jit317.
19. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., Becenti J., Kvamme S., Whitney C.G., Santosham M. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis. 2007, 196(8):1211-1220. 10.1086/521833.
20. Obaro S.K., Adegbola R.A., Chang I., Banya W.A., Jaffar S., McAdam K.W., Greenwood B.M. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to crm197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in gambian infants. Pediatr. Infect. Dis. J. 2000, 19(5):463-469.
21. Omori R., Cowling B.J., Nishiura H. How is vaccine effectiveness scaled by the transmission dynamics of interacting pathogen strains with cross-protective immunity?. PLOS ONE 2012, 7(11):e50751. 10.1371/journal.pone.0050751.
22. Ota M.O., Akinsola A., Townend J., Antonio M., Enwere G., Nsekpong D., Bojang A., Saaka M., Burton R.L., Zaman A., Goldblatt D., Adegbola R.A. The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule. Vaccine 2011, 29(16):2999-3007. 10.1016/j.vaccine.2011.01.098.
23. Raymond J., Armand-Lefevre L., Moulin F., Dabernat H., Commeau A., Gendrel D., Berche P. Nasopharyngeal colonization by Haemophilus influenzae in children living in an orphanage. Pediatr. Infect Dis. J. 2001, 20(8):779-784.
24. Rinta-Kokko H., Dagan R., Givon-Lavi N., Auranen K. Estimation of vaccine efficacy against acquisition of pneumococcal carriage. Vaccine 2009, 27(29):3831-3837.
25. Russell F.M., Carapetis J.R., Satzke C., Tikoduadua L., Waqatakirewa L., Chandra R., Seduadua A., Oftadeh S., Cheung Y.B., Gilbert G.L., Mulholland E.K. Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster. Clin. Vaccine Immunol. 2010, 17(12):1970-1976. 10.1128/CVI.00117-10.
26. Scott P., Rutjes A.W., Bermetz L., Robert N., Scott S., Lourenco T., Egger M., Low N. Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis. Vaccine 2011, 29(52):9711-9721. 10.1016/j.vaccine.2011.07.042.
27. Simell B., Auranen K., Kayhty H., Goldblatt D., Dagan R., O'Brien K.L. The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 2012, 11(7):841-855. 10.1586/erv.12.53.
28. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int. J. Epidemiol. 1984, 13(1):87-93.
29. Trotter C.L., Edmunds W.J., Ramsay M.E., Miller E. Modeling future changes to the meningococcal serogroup c conjugate (mcc) vaccine program in England and Wales. Hum. Vaccine 2006, 2(2):68-73.
30. Vakevainen M., Eklund C., Eskola J., Kayhty H. Cross-reactivity of antibodies to type 6b and 6a polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J. Infect. Dis. 2001, 184(6):789-793.
31. van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., Bruin J.P., van Alphen L., Sanders E.A. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. JAMA 2009, 302(2):159-167.